Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 1999, p. 2165-2169, Vol. 37, No. 7
Enveloppe Bactérienne, Antibiotiques et
Colonisation, CJF 96-06 INSERM, Faculté de Médecine,
Université de la Mediterranée, 13385 Marseille Cedex 05, France
Received 12 October 1998/Returned for modification 5 January
1999/Accepted 25 March 1999
The aim of this study was to determine the distribution in France
of the Enterobacter aerogenes prevalent clone isolated in the hospitals of the Marseille area (A. Davin-Regli, D. Monnet, P. Saux, C. Bosi, R. Charrel, A. Barthelemy, and C. Bollet, J. Clin.
Microbiol. 34:1474-1480, 1996). A total of 123 E. aerogenes isolates were collected from 23 hospital laboratories
and analyzed by random amplification of polymorphic DNA and
enterobacterial repetitive intergenic consensus-PCR to determine their
epidemiological relatedness. Molecular typing revealed that 21 of the
23 laboratories had isolated this prevalent clone harboring the plasmid
encoding for extended-spectrum
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Most Enterobacter aerogenes Strains in
France Belong to a Prevalent Clone
-lactamase of the TEM-24 type. Most
isolates were susceptible only to imipenem and gentamicin. Their
dissemination seems to be clonal and was probably the result of the
general use of broad-spectrum cephalosporins and quinolones. Four
isolates showed an alteration of their outer membrane proteins, causing decrease of susceptibility to third-generation cephalosporins and
imipenem and leading to the critical situation of having no alternative
therapeutic. The large dissemination of the E. aerogenes prevalent clone probably results from its good adaptation to the antibiotics administered in France and the hospital environment, particularly in intensive care units.
*
Corresponding author. Mailing address: CJF 96-06 INSERM, Faculté de Médecine, 27 Blvd. Jean Moulin, 13385 Marseille Cedex 05, France. Phone: (33) 4-91-32-45-29. Fax: (33)
4-91-32-46-06. E-mail: cbollet{at}ap-hm.fr.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|